Maternal immune activation in neurodevelopmental disorders

Developmental Dynamics

Volumn 247, Issue 4, 2018, Pages 588-619

  Solek, Cynthia M ^a   Farooqi, Nasr ^a   Verly, Myriam ^a   Lim, Tony K ^a   Ruthazer, Edward S ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

animal models; autism spectrum disorder; maternal immune activation; microglia; neurodevelopmental disorders; schizophrenia

Indexed keywords

AUTISM; BEHAVIOR; CELL ACTIVATION; HUMAN; IMMUNE SYSTEM; IMMUNITY; MATERNAL IMMUNE ACTIVATION; MENTAL DISEASE; MICROGLIA; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SYNAPSE; ACTIVE IMMUNIZATION; ANIMAL; FEMALE; PREGNANCY; PRENATAL EXPOSURE;

ANIMALS; FEMALE; HUMANS; IMMUNITY, ACTIVE; NEURODEVELOPMENTAL DISORDERS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 85038972156     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.24612     Document Type: Review

References (301)

1. Aavani T, Rana SA, Hawkes R, Pittman QJ. 2015. Maternal Immune Activation Produces Cerebellar Hyperplasia and Alterations in Motor and Social Behaviors in Male and Female Mice. Cerebellum 14:491–505.
2. Abazyan B, Nomura J, Kannan G, Ishizuka K, Tamashiro KL, Nucifora F, Pogorelov V, Ladenheim B, Yang C, Krasnova IN, Cadet JL, Pardo C, Mori S, Kamiya A, Vogel MW, Sawa A, Ross CA, Pletnikov MV. 2010. Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology. Biol Psychiatry 68:1172–1181.
3. Aguilar-Valles A, Flores C, Luheshi GN. 2010. Prenatal inflammation-induced hypoferremia alters dopamine function in the adult offspring in rat: Relevance for schizophrenia. PLoS One 5.
4. Aguilar-Valles A, Jung S, Poole S, Flores C, Luheshi GN. 2012. Leptin and interleukin-6 alter the function of mesolimbic dopamine neurons in a rodent model of prenatal inflammation. Psychoneuroendocrinology 37:956–969.
5. Aguilar-Valles A, Luheshi GN. 2011. Alterations in cognitive function and behavioral response to amphetamine induced by prenatal inflammation are dependent on the stage of pregnancy. Psychoneuroendocrinology 36:634–648.
6. Amaral DG, Schumann CM, Nordahl CW. 2008. Neuroanatomy of autism. Trends Neurosci 31:137–145.
7. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)Washington D.C: APA.
8. American Psychiatric Association. 2013. Diagnostic and Statistical Manual of Mental Disorders (DSM-5 (R)). In: Washington D.C: APA.
9. Antonson AM, Radlowski EC, Lawson MA, Rytych JL, Johnson RW. 2017. Maternal viral infection during pregnancy elicits anti-social behavior in neonatal piglet offspring independent of postnatal microglial cell activation. Brain Behav Immun 59:300–312.
10. Antony JM, Paquin A, Nutt SL, Kaplan DR, Miller FD. 2011. Endogenous microglia regulate development of embryonic cortical precursor cells. J Neurosci Res 89:286–298.
11. Arion D, Unger T, Lewis DA, Levitt P, Mirnics K. 2007. Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry 62:711–21.
12. Arrode-Brusés G, Brusés JL. 2012. Maternal immune activation by poly(I:C) induces expression of cytokines IL-1β and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brain. J Neuroinflammation 9:605.
13. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J. 2011. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 25:40–45.
14. Atanasova B, Graux J, El Hage W, Hommet C, Camus V, Belzung C. 2008. Olfaction: A potential cognitive marker of psychiatric disorders. Neurosci Biobehav Rev 32:1315–1325.
15. Atladóttir HÓ, Thorsen P, Østergaard L, Schendel DE, Lemcke S, Abdallah M, Parner ET. 2010. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 40:1423–1430.
16. Ayhan Y, McFarland R, Pletnikov MV. 2016. Animal models of gene-environment interaction in schizophrenia: A dimensional perspective. Prog Neurobiol 136:1–27.
17. Babri S, Doosti MH, Salari AA. 2014. Strain-dependent effects of prenatal maternal immune activation on anxiety- and depression-like behaviors in offspring. Brain Behav Immun 37:164–176.
18. Baharnoori M, Bhardwaj SK, Srivastava LK. 2012. Neonatal behavioral changes in rats with gestational exposure to lipopolysaccharide: A prenatal infection model for developmental neuropsychiatric disorders. Schizophr Bull 38:444–456.
19. Baharnoori M, Brake WG, Srivastava LK. 2009. Prenatal immune challenge induces developmental changes in the morphology of pyramidal neurons of the prefrontal cortex and hippocampus in rats. Schizophr Res 107:99–109.
20. Ballendine SA, Greba Q, Dawicki W, Zhang X, Gordon JR, Howland JG. 2015. Behavioral alterations in rat offspring following maternal immune activation and ELR-CXC chemokine receptor antagonism during pregnancy: Implications for neurodevelopmental psychiatric disorders. Prog Neuro-Psychopharmacology Biol Psychiatry 57:155–165.
21. Banati RB, Myers R, Kreutzberg GW. 1997. PK (‘peripheral benzodiazepine')—Binding sites in the CNS indicate early and discrete brain lesions: Microautoradiographic detection of [3H]PK 11195 binding to activated microglia. J Neurocytol 26:77–82.
22. Basta-Kaim A, Fijał K, Ślusarczyk J, Trojan E, Głombik K, Budziszewska B, Leśkiewicz M, Regulska M, Kubera M, Lasoń W, Wȩdzony K. 2015. Prenatal administration of lipopolysaccharide induces sex-dependent changes in glutamic acid decarboxylase and parvalbumin in the adult rat brain. Neuroscience 287:78–92.
23. Basta-Kaim A, Szczȩsny E, Leśkiewicz M, Głombik K, Ślusarczyk J, Budziszewska B, Regulska M, Kubera M, Nowak W, Wȩdzony K, Lasoń W. 2012. Maternal immune activation leads to age-related behavioral and immunological changes in male rat offspring—The effect of antipsychotic drugs. Pharmacol Reports 64:1400–1410.
24. Batinić B, Santrač A, Divović B, Timić T, Stanković T, Obradović AL, Joksimović S, Savić MM. 2016. Lipopolysaccharide exposure during late embryogenesis results in diminished locomotor activity and amphetamine response in females and spatial cognition impairment in males in adult, but not adolescent rat offspring. Behav Brain Res 299:72–80.
25. Batinić B, Santrač A, Jančić I, Li G, Vidojević A, Marković B, Cook JM, Savić MM. 2017. Positive modulation of α5 GABA A receptors in preadolescence prevents reduced locomotor response to amphetamine in adult female but not male rats prenatally exposed to lipopolysaccharide. Int J Dev Neurosci 61:31–39.
26. Bauman MD, Iosif A-M, Ashwood P, Braunschweig D, Lee A, Schumann CM, Van de Water J, Amaral DG. 2013. Maternal antibodies from mothers of children with autism alter brain growth and social behavior development in the rhesus monkey. Transl Psychiatry 3:e278.
27. Bauman MD, Iosif A-M, Smith SEP, Bregere C, Amaral DG, Patterson PH. 2014. Activation of the Maternal Immune System During Pregnancy Alters Behavioral Development of Rhesus Monkey Offspring. Biol Psychiatry 75:332–341.
28. Bayer TA, Buslei R, Havas L, Falkai P. 1999. Evidence for activation of microglia in patients with psychiatric illnesses. Neurosci Lett 271:126–128.
29. Beloosesky R, Maravi N, Weiner Z, Khatib N, Awad N, Boles J, Ross MG, Itskovitz-Eldor J. 2010. Maternal lipopolysaccharide-induced inflammation during pregnancy programs impaired offspring innate immune responses. Am J Obstet Gynecol 203:185.e1–185.e4.
30. Bergon A, Belzeaux R, Comte M, Pelletier F, Hervé M, Gardiner EJ, Beveridge NJ, Liu B, Carr V, Scott RJ, Kelly B, Cairns MJ, Kumarasinghe N, Schall U, Blin O, Boucraut J, Tooney PA, Fakra E, Ibrahim EC. 2015. CX3CR1 is dysregulated in blood and brain from schizophrenia patients. Schizophr Res 168:434–443.
31. Bilbo SD, Block CL, Bolton JL, Hanamsagar R, Tran PK. 2018. Beyond infection—Maternal immune activation by environmental factors, microglial development, and relevance for autism spectrum disorders. Exp Neurol 299:241–251.
32. Bitanihirwe BK, Peleg-Raibstein D, Mouttet F, Feldon J, Meyer U. 2010. Late Prenatal Immune Activation in Mice Leads to Behavioral and Neurochemical Abnormalities Relevant to the Negative Symptoms of Schizophrenia. Neuropsychopharmacology 35:2462–2478.
33. Block ML, Hong J-S. 2005. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 76:77–98.
34. Boksa P. 2010. Effects of prenatal infection on brain development and behavior: A review of findings from animal models. Brain Behav Immun 24:881–897.
35. Boksa P, Zhang Y, Nouel D, Wong A, Wong TP. 2017. Early Development of Parvalbumin-, Somatostatin-, and Cholecystokinin-Expressing Neurons in Rat Brain following Prenatal Immune Activation and Maternal Iron Deficiency. Dev Neurosci 3:342–353.
36. Bolouri H, Sävman K, Wang W, Thomas A, Maurer N, Dullaghan E, Fjell CD, Ek CJ, Hagberg H, Hancock REW, Brown KL, Mallard C. 2014. Innate defense regulator peptide 1018 protects against perinatal brain injury. Ann Neurol 75:395–410.
37. Brown AS. 2006. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull 32:200–202.
38. Brown AS. 2011. The environment and susceptibility to schizophrenia. Prog Neurobiol 93:23–58.
39. Brown AS, Derkits EJ. 2010. Prenatal infection and schizophrenia: A review of epidemiologic and translational studies. Am J Psychiatry 167:261–280.
40. Brown AS, Begg MD, Gravenstein S, Schaefer CA, Wyatt RJ, Bresnahan M, Babulas VP, Susser ES. 2004. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 61:774–780.
41. Busse S, Busse M, Schiltz K, Bielau H, Gos T, Brisch R, Mawrin C, Schmitt A, Jordan W, Müller UJ, Bernstein H-G, Bogerts B, Steiner J. 2012. Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: further evidence for disease course-related immune alterations? Brain Behav Immun 26:1273–1279.
42. Canetta S, Bolkan S, Padilla-Coreano N, Song LJ, Sahn R, Harrison NL, Gordon JA, Brown A, Kellendonk C. 2016. Maternal immune activation leads to selective functional deficits in offspring parvalbumin interneurons. Mol Psychiatry 21:956–968.
43. Careaga M, Murai T, Bauman MD. 2017. Maternal immune activation and autism spectrum disorder: From rodents to nonhuman and human primates. Biol Psychiatry 81:391–401.
44. Carter CJ, Blizard RA. 2016. Autism genes are selectively targeted by environmental pollutants including pesticides, heavy metals, bisphenol A, phthalates and many others in food, cosmetics or household products. Neurochem Int 101:83–109.
45. Casanova MF, El-Baz AS, Kamat SS, Dombroski BA, Khalifa F, Elnakib A, Soliman A, Allison-McNutt A, Switala AE. 2013. Focal cortical dysplasias in autism spectrum disorders. Acta Neuropathol Commun 1:67.
46. Chess S. 1971. Autism in children with congenital rubella. J Autism Child Schizophr 1:33–47.
47. Chez MG, Dowling T, Patel PB, Khanna P, Kominsky M. 2007. Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatr Neurol 36:361–365.
48. Choi GB, Yim YS, Wong H, Kim S, Kim H, Kim S V, Hoeffer CA, Littman DR, Huh JR. 2016. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science 351:933–939.
49. Chou S, Jones S, Li M. 2015. Adolescent olanzapine sensitization is correlated with hippocampal stem cell proliferation in a maternal immune activation rat model of schizophrenia. Brain Res 1618:122–135.
50. Christensen DL, Baio J, Van Naarden Braun K, Bilder D, Charles J, Constantino JN, Daniels J, Durkin MS, Fitzgerald RT, Kurzius-Spencer M, Lee L-C, Pettygrove S, Robinson C, Schulz E, Wells C, Wingate MS, Zahorodny W, Yeargin-Allsopp M, Centers for Disease Control and Prevention (CDC). 2016. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years—Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012. MMWR Surveill Summ 65:1–23.
51. Chua JSC, Cowley CJ, Manavis J, Rofe AM, Coyle P. 2012. Prenatal exposure to lipopolysaccharide results in neurodevelopmental damage that is ameliorated by zinc in mice. Brain Behav Immun 26:326–336.
52. Chubb JE, Bradshaw NJ, Soares DC, Porteous DJ, Millar JK. 2008. The DISC locus in psychiatric illness. Mol Psychiatry 13:36–64.
53. Coiro P, Padmashri R, Suresh A, Spartz E, Pendyala G, Chou S, Jung Y, Meays B, Roy S, Gautam N, Alnouti Y, Li M, Dunaevsky A. 2015. Impaired synaptic development in a maternal immune activation mouse model of neurodevelopmental disorders. Brain Behav Immun 50:249–258.
54. Connor CM, Dincer A, Straubhaar J, Galler JR, Houston IB, Akbarian S. 2012. Maternal immune activation alters behavior in adult offspring, with subtle changes in the cortical transcriptome and epigenome. Schizophr Res 140:175–184.
55. Crampton SJ, Collins LM, Toulouse A, Nolan YM, O'Keeffe GW. 2012. Exposure of foetal neural progenitor cells to IL-1b impairs their proliferation and alters their differentiation—A role for maternal inflammation? J Neurochem 120:964–973.
56. Cui K, Ashdown H, Luheshi GN, Boksa P. 2009. Effects of prenatal immune activation on hippocampal neurogenesis in the rat. Schizophr Res 113:288–297.
57. Cunningham CLL, Martinez-Cerdeno V, Noctor SCC, Martínez-Cerdeño V, Noctor SCC. 2013. Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J Neurosci 33:4216–4233.
58. da Silveira VT, Medeiros D de C, Ropke J, Guidine PA, Rezende GH, Moraes MFD, Mendes EMAM, Macedo D, Moreira FA, de Oliveira ACP. 2017. Effects of early or late prenatal immune activation in mice on behavioral and neuroanatomical abnormalities relevant to schizophrenia in the adulthood. Int J Dev Neurosci 58:1–8.
59. Dalton VS, Verdurand M, Walker A, Hodgson DM, Zavitsanou K. 2012. Synergistic Effect between Maternal Infection and Adolescent Cannabinoid Exposure on Serotonin 5HT1A Receptor Binding in the Hippocampus: Testing the “Two Hit” Hypothesis for the Development of Schizophrenia. Int Sch Res Netw psychiatry 2012:451865.
60. Davis J, Eyre H, Jacka FN, Dodd S, Dean O, McEwen S, Debnath M, McGrath J, Maes M, Amminger P, McGorry PD, Pantelis C, Berk M. 2016. A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis. Neurosci Biobehav Rev 65:185–194.
61. de la Torre-Ubieta L, Won H, Stein JL, Geschwind DH. 2016. Advancing the understanding of autism disease mechanisms through genetics. Nat Med 22:345–361.
62. de Souza DF, Wartchow KM, Lunardi PS, Brolese G, Tortorelli LS, Batassini C, Biasibetti R, Gonçalves C-A. 2015. Changes in Astroglial Markers in a Maternal Immune Activation Model of Schizophrenia in Wistar Rats are Dependent on Sex. Front Cell Neurosci 9:1–11.
63. Depino AM. 2015. Early prenatal exposure to LPS results in anxiety- and depression-related behaviors in adulthood. Neuroscience 299:56–65.
64. Deverman BE, Patterson PH. 2009. Cytokines and CNS Development. Neuron 64:61–78.
65. Dickerson DD, Overeem KA, Wolff AR, Williams JM, Abraham WC, Bilkey DK. 2014. Association of aberrant neural synchrony and altered GAD67 expression following exposure to maternal immune activation, a risk factor for schizophrenia. Transl Psychiatry 4:e418.
66. Doorduin J, de Vries EFJ, Willemsen ATM, de Groot JC, Dierckx RA, Klein HC. 2009. Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med 50:1801–1807.
67. Doorduin J, de Vries EF, Dierckx RA, Klein HC. 2008. PET imaging of the peripheral benzodiazepine receptor: monitoring disease progression and therapy response in neurodegenerative disorders. Curr Pharm Des 14:3297–3315.
68. Dowling O, Chatterjee PK, Gupta M, Tam Tam HB, Xue X, Lewis D, Rochelson B, Metz CN. 2012. Magnesium sulfate reduces bacterial LPS-induced inflammation at the maternal-fetal interface. Placenta 33:392–398.
69. Drenzek JG, Breburda EE, Burleigh DW, Bondarenko GI, Grendell RL, Golos TG. 2008. Expression of indoleamine 2,3-dioxygenase in the rhesus monkey and common marmoset. J Reprod Immunol 78:125–133.
70. Edmonson C, Ziats MN, Rennert OM. 2014. Altered glial marker expression in autistic post-mortem prefrontal cortex and cerebellum. Mol Autism 5:3.
71. Ellman LM, Deicken RF, Vinogradov S, Kremen WS, Poole JH, Kern DM, Tsai WY, Schaefer CA, Brown AS. 2010. Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8. Schizophr Res 121:46–54.
72. Enstrom AM, Onore CE, Van de Water JA, Ashwood P. 2010. Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun 24:64–71.
73. Estes ML, McAllister AK. 2015. Immune mediators in the brain and peripheral tissues in autism spectrum disorder. Nat Rev Neurosci 16:469–486.
74. Estes ML, McAllister AK. 2016. Maternal immune activation: Implications for neuropsychiatric disorders. Science 353:772–777.
75. Fatemi SH, Earle J, Kanodia R, Kist D, Emamian ES, Patterson PH, Shi L, Sidwell R. 2002a. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 22:25–33.
76. Fatemi SH, Emamian ES, Sidwell RW, Kist DA, Stary JM, Earle JA, Thuras P. 2002b. Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice. Mol Psychiatry 7:633–640.
77. Fatemi SH, Emamian ES, Kist D, Sidwell RW, Nakajima K, Akhter P, Shier A, Sheikh S, Bailey K. 1999. Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol Psychiatry 4:145–154.
78. Fernández M, Mollinedo-Gajate I, Peñagarikano O. 2017. Neural circuits for social cognition: Implications for autism. Neuroscience. ePub ahead of print.
79. Fernández de Cossío L, Guzmán A, van der Veldt S, Luheshi GN. 2017. Prenatal infection leads to ASD-like behavior and altered synaptic pruning in the mouse offspring. Brain Behav Immun 63:88–98.
80. Fillman SG, Cloonan N, Catts VS, Miller LC, Wong J, McCrossin T, Cairns M, Weickert CS. 2013. Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry 18:206–214.
81. Fineberg AM, Ellman LM. 2013. Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia. Biol Psychiatry 73:951–966.
82. Foley KA, MacFabe DF, Vaz A, Ossenkopp K-P, Kavaliers M. 2014. Sexually dimorphic effects of prenatal exposure to propionic acid and lipopolysaccharide on social behavior in neonatal, adolescent, and adult rats: Implications for autism spectrum disorders. Int J Dev Neurosci 39:68–78.
83. Forrest CM, Khalil OS, Pisar M, Smith RA, Darlington L, Stone TW. 2012. Prenatal activation of Toll-like receptors-3 by administration of the viral mimetic poly(I:C) changes synaptic proteins, N-methyl-D-aspartate receptors and neurogenesis markers in offspring. Mol Brain 5:22.
84. Fortier MÈ, Joober R, Luheshi GN, Boksa P. 2004. Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. J Psychiatr Res 38:335–345.
85. Fortier ME, Luheshi GN, Boksa P. 2007. Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of the infectious agent and the stage of pregnancy. Behav Brain Res 181:270–277.
86. Franco R, Fernández-Suárez D. 2015. Alternatively activated microglia and macrophages in the central nervous system. Prog Neurobiol 131:65–86.
87. Gallagher D, Norman AA, Woodard CL, Yang G, Gauthier-Fisher A, Fujitani M, Vessey JP, Cancino GI, Sachewsky N, Woltjen K, Fatt MP, Morshead CM, Kaplan DR, Miller FD. 2013. Transient Maternal IL-6 Mediates Long-Lasting Changes in Neural Stem Cell Pools by Deregulating an Endogenous Self-Renewal Pathway. Cell Stem Cell 13:564–576.
88. Galvão MC, Chaves-Kirsten GP, Queiroz-Hazarbassanov N, Carvalho VM, Bernardi MM, Kirsten TB. 2015. Prenatal zinc reduces stress response in adult rat offspring exposed to lipopolysaccharide during gestation. Life Sci 120:54–60.
89. Garay PA, Hsiao EY, Patterson PH, McAllister AK. 2013. Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development. Brain Behav Immun 31:54–68.
90. Garbett K, Ebert PJ, Mitchell A, Lintas C, Manzi B, Mirnics K, Persico AM. 2008. Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol Dis 30:303–311.
91. García-Bueno B, Gassó P, MacDowell KS, Callado LF, Mas S, Bernardo M, Lafuente A, Meana JJ, Leza JC. 2016. Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia. J Psychiatry Neurosci 41:E46–55.
92. Gekas C, Dieterlen-Lièvre F, Orkin SH, Mikkola HKA. 2005. The placenta is a niche for hematopoietic stem cells. Dev Cell 8:365–735.
93. Giovanoli S, Engler H, Engler A, Richetto J, Feldon J, Riva MA, Schedlowski M, Meyer U. 2016a. Preventive effects of minocycline in a neurodevelopmental two-hit model with relevance to schizophrenia. Transl Psychiatry 6:e772.
94. Giovanoli S, Engler H, Engler A, Richetto J, Voget M, Willi R, Winter C, Riva MA, Mortensen PB, Feldon J, Schedlowski M, Meyer U. 2013. Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science 339:1095–1099.
95. Giovanoli S, Notter T, Richetto J, Labouesse MA, Vuillermot S, Riva MA, Meyer U. 2015. Late prenatal immune activation causes hippocampal deficits in the absence of persistent inflammation across aging. J Neuroinflammation 12:221.
96. Giovanoli S, Weber-Stadlbauer U, Schedlowski M, Meyer U, Engler H. 2016b. Prenatal immune activation causes hippocampal synaptic deficits in the absence of overt microglia anomalies. Brain Behav Immun 55:25–38.
97. Goh S, Peterson BS. 2012. Imaging evidence for disturbances in multiple learning and memory systems in persons with autism spectrum disorders. Dev Med Child Neurol 54:208–213.
98. Goines P, Van de Water J. 2010. The immune system's role in the biology of autism. Curr Opin Neurol 23:111–117.
99. Green MF. 1996. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153:321–330.
100. Hahn ME, Lavooy MJ. 2005. A review of the methods of studies on infant ultrasound production and maternal retrieval in small rodents. Behav Genet 35:31–52.
101. Halim ND, Weickert CS, McClintock BW, Hyde TM, Weinberger DR, Kleinman JE, Lipska BK. 2003. Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development. Mol Psychiatry 8:797–810.
102. Han M, Zhang J-C, Hashimoto K. 2017. Increased Levels of C1q in the Prefrontal Cortex of Adult Offspring after Maternal Immune Activation: Prevention by 7,8-Dihydroxyflavone. Clin Psychopharmacol Neurosci 15:64–67.
103. Han M, Zhang J, Yao W, Yang C, Ishima T, Ren Q, Ma M, Dong C, Huang X-F, Hashimoto K. 2016. Intake of 7,8-Dihydroxyflavone During Juvenile and Adolescent Stages Prevents Onset of Psychosis in Adult Offspring After Maternal Immune Activation. Sci Rep 6:36087.
104. Han X, Li N, Meng Q, Shao F, Wang W. 2011. Maternal immune activation impairs reversal learning and increases serum tumor necrosis factor-α in offspring. Neuropsychobiology 64:9–14.
105. Hanamsagar R, Bilbo SD. 2017. Environment matters: microglia function and dysfunction in a changing world. Curr Opin Neurobiol 47:146–155.
106. Hansen SN, Schendel DE, Parner ET. 2015. Explaining the increase in the prevalence of autism spectrum disorders: the proportion attributable to changes in reporting practices. JAMA Pediatr 169:56–62.
107. Hao LY, Hao XQ, Li SH, Li XH. 2010. Prenatal exposure to lipopolysaccharide results in cognitive deficits in age-increasing offspring rats. Neuroscience 166:763–770.
108. Harvey L, Boksa P. 2014. Additive effects of maternal iron deficiency and prenatal immune activation on adult behaviors in rat offspring. Brain Behav Immun 40:27–37.
109. Hertz-Picciotto I, Delwiche L. 2009. The rise in autism and the role of age at diagnosis. Epidemiology 20:84–90.
110. Heuer L, Ashwood P, Schauer J, Goines P, Krakowiak P, Hertz-Picciotto I, Hansen R, Croen LA, Pessah IN, Van de Water J. 2008. Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Res 1:275–283.
111. Hodyl NA, Krivanek KM, Lawrence E, Clifton VL, Hodgson DM. 2007. Prenatal exposure to a pro-inflammatory stimulus causes delays in the development of the innate immune response to LPS in the offspring. J Neuroimmunol 190:61–71.
112. Holloway T, Moreno JL, Umali A, Rayannavar V, Hodes GE, Russo SJ, Gonzalez-Maeso J. 2013. Prenatal Stress Induces Schizophrenia-Like Alterations of Serotonin 2A and Metabotropic Glutamate 2 Receptors in the Adult Offspring: Role of Maternal Immune System. J Neurosci 33:1088–1098.
113. Hong S, Dissing-Olesen L, Stevens B. 2016. New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 36:128–134.
114. Hong S, Stevens B. 2016. Microglia: Phagocytosing to Clear, Sculpt, and Eliminate. Dev Cell 38:126–128.
115. Horváth S, Mirnics K. 2014. Immune system disturbances in schizophrenia. Biol Psychiatry 75:316–323.
116. Howland JG, Cazakoff BN, Zhang Y. 2012. Altered object-in-place recognition memory, prepulse inhibition, and locomotor activity in the offspring of rats exposed to a viral mimetic during pregnancy. Neuroscience 201:184–198.
117. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, Patterson PH, Mazmanian SK. 2013. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155:1451–1463.
118. Hsiao EY, Patterson PH. 2012. Placental regulation of maternal-fetal interactions and brain development. Dev Neurobiol 72:1317–1326.
119. Hsueh PT, Wang HH, Liu CL, Ni WF, Chen YL, Liu JK. 2017. Expression of cerebral serotonin related to anxiety-like behaviors in C57BL/6 offspring induced by repeated subcutaneous prenatal exposure to low-dose lipopolysaccharide. PLoS One 12:1–26.
120. Hyman SL, Arndt TL, Rodier PM. 2005. Environmental agents and autism: once and future associations. Int Rev Res Ment Retard 30:171–194.
121. Inta D, Lang UE, Borgwardt S, Meyer-lindenberg A, Gass P. 2017. Microglia Activation and Schizophrenia: Lessons From the Effects of Minocycline on Postnatal Neurogenesis, Neuronal Survival and Synaptic Pruning. Schizophr Bull 43:493–496.
122. Ito HT, Smith SEP, Hsiao E, Patterson PH. 2010. Maternal immune activation alters nonspatial information processing in the hippocampus of the adult offspring. Brain Behav Immun 24:930–941.
123. Johnson CP, Myers SM, American Academy of Pediatrics Council on Children With Disabilities. 2007. Identification and evaluation of children with autism spectrum disorders. Pediatrics 120:1183–1215.
124. Juckel G, Manitz MP, Brüne M, Friebe A, Heneka MT, Wolf RJ. 2011. Microglial activation in a neuroinflammational animal model of schizophrenia—a pilot study. Schizophr Res 131:96–100.
125. Keil A, Daniels JL, Forssen U, Hultman C, Cnattingius S, Söderberg KC, Feychting M, Sparen P. 2010. Parental autoimmune diseases associated with autism spectrum disorders in offspring. Epidemiology 21:805–808.
126. Kenk M, Selvanathan T, Rao N, Suridjan I, Rusjan P, Remington G, Meyer JH, Wilson AA, Houle S, Mizrahi R. 2015. Imaging neuroinflammation in gray and white matter in schizophrenia: An in-vivo PET study with [18 F]-FEPPA. Schizophr Bull 41:85–93.
127. Kentner AC, Khoury A, Lima Queiroz E, MacRae M. 2016. Environmental enrichment rescues the effects of early life inflammation on markers of synaptic transmission and plasticity. Brain Behav Immun 57:151–160.
128. Kettenmann H, Hanisch U-KK, Noda M, Verkhratsky A. 2011. Physiology of microglia. Physiol Rev 91:461–553.
129. Khandaker GM, Cousins L, Deakin J, Lennox BR, Yolken R, Jones PB. 2015. Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry 2:258–270.
130. Kirsten TB, Bernardi MM. 2017. Prenatal lipopolysaccharide induces hypothalamic dopaminergic hypoactivity and autistic-like behaviors: Repetitive self-grooming and stereotypies. Behav Brain Res 331:25–29.
131. Kirsten TB, Lippi LL, Bevilacqua E, Bernardi MM. 2013. LPS exposure increases maternal corticosterone levels, causes placental injury and increases IL-1B levels in adult rat offspring: Relevance to autism. PLoS One 8:1–10.
132. Kirsten TB, Queiroz-Hazarbassanov N, Bernardi MM, Felicio LF. 2015. Prenatal zinc prevents communication impairments and BDNF disturbance in a rat model of autism induced by prenatal lipopolysaccharide exposure. Life Sci 130:12–17.
133. Kneeland RE, Fatemi SH. 2013. Viral infection, inflammation and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 42:35–48.
134. Knuesel I, Chicha L, Britschgi M, Schobel SA, Bodmer M, Hellings JA, Toovey S, Prinssen EP. 2014. Maternal immune activation and abnormal brain development across CNS disorders. Nat Rev Neurol 10:643–660.
135. Kohane IS, McMurry A, Weber G, MacFadden D, Rappaport L, Kunkel L, Bickel J, Wattanasin N, Spence S, Murphy S, Churchill S. 2012. The co-morbidity burden of children and young adults with autism spectrum disorders. PLoS One 7:e33224.
136. Kristiansen LV, Huerta I, Beneyto M, Meador-Woodruff JH. 2007. NMDA receptors and schizophrenia. Curr Opin Pharmacol 7:48–55.
137. Kumar U, Mohanty B. 2015. Atypical antipsychotic paliperidone prevents behavioral deficits in mice prenatally challenged with bacterial endotoxin lipopolysaccharide. Eur J Pharmacol 747:181–189.
138. Lanté F, Meunier J, Guiramand J, De Ferreira MCJ, Cambonie G, Aimar R, Cohen-Solal C, Maurice T, Vignes M, Barbanel G. 2008. Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation. Hippocampus 18:602–609.
139. Lanté F, Meunier J, Guiramand J, Maurice T, Cavalier M, de Jesus Ferreira MC, Aimar R, Cohen-Solal C, Vignes M, Barbanel G. 2007. Neurodevelopmental damage after prenatal infection: Role of oxidative stress in the fetal brain. Free Radic Biol Med 42:1231–1245.
140. Laskaris LE, Di Biase MA, Everall I, Chana G, Christopoulos A, Skafidas E, Cropley VL, Pantelis C. 2016. Microglial activation and progressive brain changes in schizophrenia. Br J Pharmacol 173:666–680.
141. Leboyer M, Oliveira J, Tamouza R, Groc L. 2016. Is it time for immunopsychiatry in psychotic disorders? Psychopharmacology (Berl) 233:1651–1660.
142. Lin YL, Lin SY, Wang S. 2012. Prenatal lipopolysaccharide exposure increases anxiety-like behaviors and enhances stress-induced corticosterone responses in adult rats. Brain Behav Immun 26:459–468.
143. Lin YL, Wang S. 2014. Prenatal lipopolysaccharide exposure increases depression-like behaviors and reduces hippocampal neurogenesis in adult rats. Behav Brain Res 259:24–34.
144. Lipina TV, Zai C, Hlousek D, Roder JC, Wong AHC. 2013. Maternal Immune Activation during Gestation Interacts with Disc1 Point Mutation to Exacerbate Schizophrenia-Related Behaviors in Mice. J Neurosci 33:7654–7666.
145. Liu YH, Lai WS, Tsay HJ, Wang TW, Yu JY. 2013. Effects of maternal immune activation on adult neurogenesis in the subventricular zone-olfactory bulb pathway and olfactory discrimination. Schizophr Res 151:1–11.
146. Lord C, Cook EH, Leventhal BL, Amaral DG. 2000. Autism spectrum disorders. Neuron 28:355–363.
147. Lowe GC, Luheshi GN, Williams S. 2008. Maternal infection and fever during late gestation are associated with altered synaptic transmission in the hippocampus of juvenile offspring rats. AJP Regul Integr Comp Physiol 295:R1563–R1571.
148. Luchicchi A, Lecca S, Melis M, De Felice M, Cadeddu F, Frau R, Muntoni AL, Fadda P, Devoto P, Pistis M. 2016. Maternal immune activation disrupts dopamine system in the offspring. Int J Neuropsychopharmacol 19:1–10.
149. Machado CJ, Whitaker AM, Smith SEP, Patterson PH, Bauman MD. 2015. Maternal immune activation in nonhuman primates alters social attention in juvenile offspring. Biol Psychiatry 77:823–832.
150. Makinodan M, Tatsumi K, Manabe T, Yamauchi T, Makinodan E, Matsuyoshi H, Shimoda S, Noriyama Y, Kishinioto T, Wanaka A. 2008. Maternal immune activation in mice delays myelination and axonal development in the hippocampus of the offspring. J Neurosci Res 86:2190–2200.
151. Malkova N, Gallagher JJ, Yu CZ, Jacobs RE, Patterson PH. 2014. Manganese-enhanced magnetic resonance imaging reveals increased DOI-induced brain activity in a mouse model of schizophrenia. Proc Natl Acad Sci USA 111:E2492–E2500.
152. Malkova NV, Yu CZ, Hsiao EY, Moore MJ, Patterson PH. 2012. Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav Immun 26:607–616.
153. Mandelli L, Toscano E, Porcelli S, Fabbri C, Serretti A. 2016. Onset age in schizophrenia spectrum disorders: Complex interactions between genetic and environmental factors. Psychiatry Investig 13:247–249.
154. Manitz MP, Plümper J, Demir S, Ahrens M, Eßlinger M, Wachholz S, Eisenacher M, Juckel G, Friebe A. 2016. Flow cytometric characterization of microglia in the offspring of PolyI:C treated mice. Brain 1636:172–182.
155. Marín O. 2012. Interneuron dysfunction in psychiatric disorders. Nat Rev Neurosci 13:107–120.
156. Martin LA, Ashwood P, Braunschweig D, Cabanlit M, Van de Water J, Amaral DG. 2008. Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav Immun 22:806–816.
157. Masi A, Quintana DS, Glozier N, Lloyd AR, Hickie IB, Guastella AJ. 2015. Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Mol Psychiatry 20:440–446.
158. Mattei D, Djodari-Irani A, Hadar R, Pelz A, de Cossío LF, Goetz T, Matyash M, Kettenmann H, Winter C, Wolf SA. 2014. Minocycline rescues decrease in neurogenesis, increase in microglia cytokines and deficits in sensorimotor gating in an animal model of schizophrenia. Brain Behav Immun 38:175–184.
159. McDougle CJ, Landino SM, Vahabzadeh A, O'Rourke J, Zurcher NR, Finger BC, Palumbo ML, Helt J, Mullett JE, Hooker JM, Carlezon WA. 2015. Toward an immune-mediated subtype of autism spectrum disorder. Brain Res 1617:72–92.
160. Mednick SA, Machon RA, Huttunen MO, Bonett D. 1988. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 45:189–192.
161. Meehan C, Harms L, Frost JD, Barreto R, Todd J, Schall U, Shannon Weickert C, Zavitsanou K, Michie PT, Hodgson DM. 2017. Effects of immune activation during early or late gestation on schizophrenia-related behaviour in adult rat offspring. Brain Behav Immun 63:8–20.
162. Melnik A, Tauber S, Dumrese C, Ullrich O, Wolf SA. 2012. Murine adult neural progenitor cells alter their proliferative behavior and gene expression after the activation of toll-like-receptor 3. Eur J Microbiol Immunol 2:239–248.
163. Meyer U. 2006. The Time of Prenatal Immune Challenge Determines the Specificity of Inflammation-Mediated Brain and Behavioral Pathology. J Neurosci 26:4752–4762.
164. Meyer U, Murray PJ, Urwyler A, Yee BK, Schedlowski M, Feldon J. 2008a. Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol Psychiatry 13:208–221.
165. Meyer U. 2013. Developmental neuroinflammation and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 42:20–34.
166. Meyer U. 2014. Prenatal Poly(I:C) exposure and other developmental immune activation models in rodent systems. Biol Psychiatry 75:307–315.
167. Meyer U, Feldon J, Fatemi SH. 2009a. In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci Biobehav Rev 33:1061–1079.
168. Meyer U, Feldon J, Schedlowski M, Yee BK. 2005. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev 29:913–947.
169. Meyer U, Feldon J, Yee BK. 2009b. A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull 35:959–972.
170. Meyer U, Nyffeler M, Yee BK, Knuesel I, Feldon J. 2008b. Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun 22:469–486.
171. Millar JK. 2000. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 9:1415–1423.
172. Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. 2011. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70:663–71.
173. Missault S, Van den Eynde K, Vanden Berghe W, Fransen E, Weeren A, Timmermans JP, Kumar-singh S, Dedeurwaerdere S. 2014. The risk for behavioural deficits is determined by the maternal immune response to prenatal immune challenge in a neurodevelopmental model. Brain Behav Immun 42:138–146.
174. Molloy CA, Morrow AL, Meinzen-Derr J, Schleifer K, Dienger K, Manning-Courtney P, Altaye M, Wills-Karp M. 2006. Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol 172:198–205.
175. Monji A, Kato T, Kanba S. 2009. Cytokines and schizophrenia: Microglia hypothesis of schizophrenia. Psychiatry Clin Neurosci 63:257–265.
176. Moreno JL, Kurita M, Holloway T, Lopez J, Cadagan R, Martinez-Sobrido L, Garcia-Sastre A, Gonzalez-Maeso J. 2011. Maternal Influenza Viral Infection Causes Schizophrenia-Like Alterations of 5-HT2A and mGlu2 Receptors in the Adult Offspring. J Neurosci 31:1863–1872.
177. Morgan JT, Chana G, Abramson I, Semendeferi K, Courchesne E, Everall IP. 2012. Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autism. Brain Res 1456:72–81.
178. Morgan JT, Chana G, Pardo CA, Achim C, Semendeferi K, Buckwalter J, Courchesne E, Everall IP. 2010. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol Psychiatry 68:368–376.
179. Mortensen PB, Nørgaard-Pedersen B, Waltoft BL, Sørensen TL, Hougaard D, Yolken RH. 2007. Early infections of Toxoplasma gondii and the later development of schizophrenia. Schizophr Bull 33:741–744.
180. Mosser C-A, Baptista S, Arnoux I, Audinat E. 2017. Microglia in CNS development: shaping the brain for the future. Prog Neurobiol 149–150:1–20.
181. Mottahedin A, Ardalan M, Chumak T, Riebe I, Ek J, Mallard C. 2017. Effect of Neuroinflammation on Synaptic Organization and Function in the Developing Brain: Implications for Neurodevelopmental and Neurodegenerative Disorders. Front Cell Neurosci 11:1–16.
182. Moy SS, Nadler JJ. 2008. Advances in behavioral genetics: mouse models of autism. Mol Psychiatry 13:4–26.
183. Müller N, Schwarz MJ. 2010. Immune System and Schizophrenia. Curr Immunol Rev 6:213–220.
184. Müller N, Weidinger E, Leitner B, Schwarz MJ. 2015. The role of inflammation in schizophrenia. Front Neurosci 9:372.
185. Murray BG, Davies DA, Molder JJ, Howland JG. 2017. Maternal immune activation during pregnancy in rats impairs working memory capacity of the offspring. Neurobiol Learn Mem 141:150–156.
186. Na K-S, Jung H-Y, Kim Y-K. 2014. The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia. Prog Neuro-Psychopharmacology Biol Psychiatry 48:277–286.
187. Naviaux JC, Schuchbauer MA, Li K, Wang L, Risbrough VB, Powell SB, Naviaux RK. 2014. Reversal of autism-like behaviors and metabolism in adult mice with single-dose antipurinergic therapy. Transl Psychiatry 4:e400.
188. Naviaux RK, Zolkipli Z, Wang L, Nakayama T, Naviaux JC, Le TP, Schuchbauer MA, Rogac M, Tang Q, Dugan LL, Powell SB. 2013. Antipurinergic Therapy Corrects the Autism-Like Features in the Poly(IC) Mouse Model. PLoS One 8.
189. Nayak D, Roth TL, McGavern DB. 2014. Microglia development and function. Annu Rev Immunol 32:367–402.
190. Onore CE, Schwartzer JJ, Careaga M, Berman RF, Ashwood P. 2014. Maternal immune activation leads to activated inflammatory macrophages in offspring. Brain Behav Immun 38:220–226.
191. Paolicelli RCC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, Giustetto M, Ferreira TAA, Guiducci E, Dumas L, Ragozzino D, Gross CTT. 2011. Synaptic pruning by microglia is necessary for normal brain development. Science 333:1456–1458.
192. Pardo CA, Vargas DL, Zimmerman AW. 2005. Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry 17:485–495.
193. Patrich E, Piontkewitz Y, Peretz A, Weiner I, Attali B. 2016. Maternal immune activation produces neonatal excitability defects in offspring hippocampal neurons from pregnant rats treated with poly I:C. Sci Rep 6:19106.
194. Patterson PH. 2011. Maternal infection and immune involvement in autism. Trends Mol Med 17:389–394.
195. Patterson PH. 2009. Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res 204:313–321.
196. Paulsen JS, Heaton RK, Sadek JR, Perry W, Delis DC, Braff D, Kuck J, Zisook S, Jeste D V. 1995. The nature of learning and memory impairments in schizophrenia. J Int Neuropsychol Soc 1:88–99.
197. Paylor JW, Lins BR, Greba Q, Moen N, de Moraes RS, Howland JG, Winship IR. 2016. Developmental disruption of perineuronal nets in the medial prefrontal cortex after maternal immune activation. Sci Rep 6:37580.
198. Penzes P, Cahill ME, Jones KA, VanLeeuwen J-E, Woolfrey KM. 2011. Dendritic spine pathology in neuropsychiatric disorders. Nat Neurosci 14:285–293.
199. Pérez-Neri I, Ramírez-Bermúdez J, Montes S, Ríos C. 2006. Possible mechanisms of neurodegeneration in schizophrenia. Neurochem Res 31:1279–1294.
200. Perry VH, Holmes C. 2014. Microglial priming in neurodegenerative disease. Nat Rev Neurol 10:217–24.
201. Persico AM, Bourgeron T. 2006. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci 29:349–58.
202. Petrelli F, Pucci L, Bezzi P. 2016. Astrocytes and Microglia and Their Potential Link with Autism Spectrum Disorders. Front Cell Neurosci 10:1–8.
203. Pineda E, Shin D, You SJ, Auvin S, Sankar R, Mazarati A. 2013. Maternal immune activation promotes hippocampal kindling epileptogenesis in mice. Ann Neurol 74:11–19.
204. Piontkewitz Y, Arad M, Weiner I. 2011. Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia. Schizophr Bull 37:1257–1269.
205. Piontkewitz Y, Bernstein HG, Dobrowolny H, Bogerts B, Weiner I, Keilhoff G. 2012. Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats. Brain Behav Immun 26:353–363.
206. Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. 2008. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63:801–808.
207. Pratt L, Ni L, Ponzio NM, Jonakait GM. 2013. Maternal inflammation promotes fetal microglial activation and increased cholinergic expression in the fetal basal forebrain: role of interleukin-6. Pediatr Res 74:393–401.
208. Radewicz K, Garey LJ, Gentleman SM, Reynolds R. 2000. Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics. J Neuropathol Exp Neurol 59:137–150.
209. Ransohoff RM, Perry VH. 2009. Microglial Physiology: Unique Stimuli, Specialized Responses. Annu Rev Immunol 27:119–145.
210. Rapoport JL, Giedd JN, Gogtay N. 2012. Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry 17:1228–1238.
211. Reisinger S, Khan D, Kong E, Berger A, Pollak A, Pollak DD. 2015. The Poly(I:C)-induced maternal immune activation model in preclinical neuropsychiatric drug discovery. Pharmacol Ther 149:213–226.
212. Richard MD, Brahm NC. 2012. Schizophrenia and the immune system: pathophysiology, prevention, and treatment. Am J Health Syst Pharm 69:757–766.
213. Richtand NM, Ahlbrand R, Horn P, Stanford K, Bronson SL, McNamara RK. 2011. Effects of risperidone and paliperidone pre-treatment on locomotor response following prenatal immune activation. J Psychiatr Res 45:1194–1201.
214. Rodriguez JI, Kern JK. 2011. Evidence of microglial activation in autism and its possible role in brain underconnectivity. Neuron Glia Biol 7:205–213.
215. Ronovsky M, Berger S, Zambon A, Reisinger SN, Horvath O, Pollak A, Lindtner C, Berger A, Pollak DD. 2017. Maternal immune activation transgenerationally modulates maternal care and offspring depression-like behavior. Brain Behav Immun 63:127–136.
216. Rose DR, Careaga M, Van de Water J, McAllister K, Bauman MD, Ashwood P. 2017. Long-term altered immune responses following fetal priming in a non-human primate model of maternal immune activation. Brain Behav Immun 63:60–70.
217. Rössler W, Joachim Salize H, Van Os J, Riecher-Rössler A. 2005. Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol 15:399–409.
218. Rott R, Herzog S, Fleischer B, Winokur A, Amsterdam J, Dyson W, Koprowski H. 1985. Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders. Science 228:755–756.
219. Ruskin DN, Murphy MI, Slade SL, Masino SA. 2017. Ketogenic diet improves behaviors in a maternal immune activation model of autism spectrum disorder. PLoS One 12:1–14.
220. Saetre P, Emilsson L, Axelsson E, Kreuger J, Lindholm E, Jazin E. 2007. Inflammation-related genes up-regulated in schizophrenia brains. BMC Psychiatry 7:46.
221. Saha S, Chant D, Welham J, McGrath J. 2005. A systematic review of the prevalence of schizophrenia. PLoS Med 2:e141.
222. Salter MW, Stevens B. 2017. Microglia emerge as central players in brain disease. Nat Med 23:1018–1027.
223. Samuelsson A-M, Jennische E, Hansson H-A, Holmäng A. 2006. Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABAA dysregulation and impaired spatial learning. AJP Regul Integr Comp Physiol 290:R1345–R1356.
224. Sandin S, Lichtenstein P, Kuja-Halkola R, Larsson H, Hultman CM, Reichenberg A. 2014. The familial risk of autism. JAMA 311:1770–1777.
225. Sarlus H, Heneka MT. 2017. Microglia in Alzheimer's disease. J Clin Invest 127:3240–3249.
226. Sasaki T, Oga T, Nakagaki K, Sakai K, Sumida K, Hoshino K, Miyawaki I, Saito K, Suto F, Ichinohe N. 2014. Developmental expression profiles of axon guidance signaling and the immune system in the marmoset cortex: Potential molecular mechanisms of pruning of dendritic spines during primate synapse formation in late infancy and prepuberty (I). Biochem Biophys Res Commun 444:302–306.
227. Schmidt LS, Miller AD, Lester DB, Bay-Richter C, Schülein C, Frikke-Schmidt H, Wess J, Blaha CD, Woldbye DPD, Fink-Jensen A, Wortwein G. 2010. Increased amphetamine-induced locomotor activity, sensitization, and accumbal dopamine release in M5 muscarinic receptor knockout mice. Psychopharmacology (Berl) 207:547–558.
228. Schwartzer JJ, Careaga M, Onore CE, Rushakoff JA, Berman RF, Ashwood P. 2013. Maternal immune activation and strain specific interactions in the development of autism-like behaviors in mice. Transl Psychiatry 3:e240.
229. Schwendener S, Meyer U, Feldon J. 2009. Deficient maternal care resulting from immunological stress during pregnancy is associated with a sex-dependent enhancement of conditioned fear in the offspring. J Neurodev Disord 1:15–32.
230. Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, Tooley K, Presumey J, Baum M, Van Doren V, Genovese G, Rose SA, Handsaker RE, Schizophrenia Working Group of the Psychiatric Genomics Consortium, Daly MJ, Carroll MC, Stevens B, McCarroll SA. 2016. Schizophrenia risk from complex variation of complement component 4. Nature 530:177–183.
231. Shi L, Fatemi SH, Sidwell RW, Patterson PH. 2003. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 23:297–302.
232. Shi L, Smith SEP, Malkova N, Tse D, Su Y, Patterson PH. 2009. Activation of the maternal immune system alters cerebellar development in the offspring. Brain Behav Immun 23:116–123.
233. Silverman JL, Yang M, Lord C, Crawley JN. 2010. Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci 11:490–502.
234. Smith PLP, Hagberg H, Naylor AS, Mallard C. 2014. Neonatal peripheral immune challenge activates microglia and inhibits neurogenesis in the developing murine hippocampus. Dev Neurosci 36:119–131.
235. Smith SEP, Li J, Garbett K, Mirnics K, Patterson PH. 2007. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 27:10695–10702.
236. Smolders S, Smolders SMT, Swinnen N, Gärtner A, Rigo J-M, Legendre P, Brône B. 2015. Maternal immune activation evoked by polyinosinic:polycytidylic acid does not evoke microglial cell activation in the embryo. Front Cell Neurosci 9:301.
237. Sperner-Unterweger B. 2005. Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications. Drugs 65:1493–1520.
238. Squarzoni P, Oller G, Hoeffel G, Pont-Lezica L, Rostaing P, Low D, Bessis A, Ginhoux F, Garel S. 2014. Microglia Modulate Wiring of the Embryonic Forebrain. Cell Rep 8:1271–1279.
239. Steiner J, Bielau H, Brisch R, Danos P, Ullrich O, Mawrin C, Bernstein H-G, Bogerts B. 2008. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res 42:151–157.
240. Steiner J, Mawrin C, Ziegeler A, Bielau H, Ullrich O, Bernstein H-G, Bogerts B. 2006. Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization. Acta Neuropathol 112:305–316.
241. Stoner R, Chow ML, Boyle MP, Sunkin SM, Mouton PR, Roy S, Wynshaw-Boris A, Colamarino SA, Lein ES, Courchesne E. 2014. Patches of Disorganization in the Neocortex of Children with Autism. N Engl J Med 370:1209–1219.
242. Straley ME, Van Oeffelen W, Theze S, Sullivan AM, O'Mahony SM, Cryan JF, O'Keeffe GW. 2017. Distinct alterations in motor & reward seeking behavior are dependent on the gestational age of exposure to LPS-induced maternal immune activation. Brain Behav Immun 63:21–34.
243. Stridh L, Mottahedin A, Johansson ME, Valdez RC, Northington F, Wang X, Mallard C. 2013. Toll-like receptor-3 activation increases the vulnerability of the neonatal brain to hypoxia-ischemia. J Neurosci 33:12041–12051.
244. Stuart MJ, Singhal G, Baune BT. 2015. Systematic Review of the Neurobiological Relevance of Chemokines to Psychiatric Disorders. Front Cell Neurosci 9:357.
245. Suzuki K, Sugihara G, Ouchi Y, Nakamura K, Futatsubashi M, Takebayashi K, Yoshihara Y, Omata K, Matsumoto K, Tsuchiya KJ, Iwata Y, Tsujii M, Sugiyama T, Mori N. 2013. Microglial activation in young adults with autism spectrum disorder. JAMA Psychiatry 70:49–58.
246. Sweeten TL, Posey DJ, McDougle CJ. 2003. High blood monocyte counts and neopterin levels in children with autistic disorder. Am J Psychiatry 160:1691–1693.
247. Swerdlow NR, Braff DL, Geyer MA. 2016. Sensorimotor gating of the startle reflex: what we said 25 years ago, what has happened since then, and what comes next. J Psychopharmacol 30:1072–1081.
248. Takano A, Arakawa R, Ito H, Tateno A, Takahashi H, Matsumoto R, Okubo Y, Suhara T. 2010. Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106. Int J Neuropsychopharmacol 13:943–950.
249. Takano T. 2015. Role of Microglia in Autism: Recent Advances. Dev Neurosci 37:195–202.
250. Taylor P V, Veenema AH, Paul MJ, Bredewold R, Isaacs S, de Vries GJ. 2012. Sexually dimorphic effects of a prenatal immune challenge on social play and vasopressin expression in juvenile rats. Biol Sex Differ 3:15.
251. Tetreault NA, Hakeem AY, Jiang S, Williams BA, Allman E, Wold BJ, Allman JM. 2012. Microglia in the cerebral cortex in autism. J Autism Dev Disord 42:2569–2584.
252. Thompson PM, Vidal C, Giedd JN, Gochman P, Blumenthal J, Nicolson R, Toga AW, Rapoport JL. 2001. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci U S A 98:11650–11655.
253. Tiwari PC, Pal R. 2017. The potential role of neuroinflammation and transcription factors in Parkinson disease. Dialogues Clin Neurosci 19:71–80.
254. Tremblay ME, Lowery RL, Majewska AK. 2010. Microglial interactions with synapses are modulated by visual experience. PLoS Biol 8:e1000527.
255. Tsukada T, Simamura E, Shimada H, Arai T, Higashi N, Akai T, Iizuka H, Hatta T. 2015. The suppression of maternal-fetal leukemia inhibitory factor signal relay pathway by maternal immune activation impairs brain development in mice. PLoS One 10:1–14.
256. Upthegrove R, Manzanares-Teson N, Barnes NM. 2014. Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis. Schizophr Res 155:101–108.
257. van Berckel BN, Bossong MG, Boellaard R, Kloet R, Schuitemaker A, Caspers E, Luurtsema G, Windhorst AD, Cahn W, Lammertsma AA, Kahn RS. 2008. Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol Psychiatry 64:820–822.
258. Van den Eynde K, Missault S, Fransen E, Raeymaekers L, Willems R, Drinkenburg W, Timmermans JP, Kumar-Singh S, Dedeurwaerdere S. 2014. Hypolocomotive behaviour associated with increased microglia in a prenatal immune activation model with relevance to schizophrenia. Behav Brain Res 258:179–186.
259. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. 2005. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57:67–81.
260. Varghese M, Keshav N, Jacot-Descombes S, Warda T, Wicinski B, Dickstein DL, Harony-Nicolas H, de Rubeis S, Drapeau E, Buxbaum JD, Hof PR. 2017. Autism spectrum disorder: neuropathology and animal models. Acta Neuropathol 134:1–30.
261. Vernon AC, So PW, Lythgoe DJ, Chege W, Cooper JD, Williams SCR, Kapur S. 2015. Longitudinal in vivo maturational changes of metabolites in the prefrontal cortex of rats exposed to polyinosinic-polycytidylic acid in utero. Eur Neuropsychopharmacol 25:2210–2220.
262. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, Mill J, Cantor RM, Blencowe BJ, Geschwind DH. 2011. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474:380–384.
263. Volk DW. 2017. Role of microglia disturbances and immune-related marker abnormalities in cortical circuitry dysfunction in schizophrenia. Neurobiol Dis 99:58–65.
264. Vorhees CV, Graham DL, Braun AA, Schaefer TL, Skelton MR, Richtand NM, Williams MT. 2012. Prenatal immune challenge in rats: Altered responses to dopaminergic and glutamatergic agents, prepulse inhibition of acoustic startle, and reduced route-based learning as a function of maternal body weight gain after prenatal exposure to poly IC. Synapse 66:725–737.
265. Vorhees CV, Graham DL, Braun AA, Schaefer TL, Skelton MR, Richtand NM, Williams MT. 2015. Prenatal immune challenge in rats: Effects of polyinosinic-polycytidylic acid on spatial learning, prepulse inhibition, conditioned fear, and responses to MK-801 and amphetamine. Neurotoxicol Teratol 47:54–65.
266. Vuillermot S, Joodmardi E, Perlmann T, Ove Ogren S, Feldon J, Meyer U. 2012. Prenatal Immune Activation Interacts with Genetic Nurr1 Deficiency in the Development of Attentional Impairments. J Neurosci 32:436–451.
267. Vuillermot S, Weber L, Feldon J, Meyer U. 2010. A Longitudinal Examination of the Neurodevelopmental Impact of Prenatal Immune Activation in Mice Reveals Primary Defects in Dopaminergic Development Relevant to Schizophrenia. J Neurosci 30:1270–1287.
268. Wallace K, Veerisetty S, Paul I, May W, Miguel-Hidalgo JJ, Bennett W. 2010. Prenatal infection decreases calbindin, decreases purkinje cell volume and density and produces long-term motor deficits in Sprague-Dawley rats. Dev Neurosci 32:302–312.
269. Weir RK, Forghany R, Smith SEP, Patterson PH, McAllister AK, Schumann CM, Bauman MD. 2015. Preliminary evidence of neuropathology in nonhuman primates prenatally exposed to maternal immune activation. Brain Behav Immun 48:139–146.
270. Wierzba-Bobrowicz T, Lewandowska E, Lechowicz W, Stepień T, Pasennik E. 2005. Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics. Folia Neuropathol 43:81–89.
271. Willette AA, Lubach GR, Knickmeyer RC, Short SJ, Styner M, Gilmore JH, Coe CL. 2011. Brain enlargement and increased behavioral and cytokine reactivity in infant monkeys following acute prenatal endotoxemia. Behav Brain Res 219:108–115.
272. 2A and mGlu2/3 receptor function in the adult male and female rat offspring. Neuropharmacology 97:275–288.
273. Wischhof L, Irrsack E, Osorio C, Koch M. 2015b. Prenatal LPS-exposure—a neurodevelopmental rat model of schizophrenia—differentially affects cognitive functions, myelination and parvalbumin expression in male and female offspring. Prog Neuropsychopharmacology Biol Psychiatry 57:17–30.
274. Wolff AR, Bilkey DK. 2008. Immune activation during mid-gestation disrupts sensorimotor gating in rat offspring. Behav Brain Res 190:156–159.
275. Wolff AR, Bilkey DK. 2010. The maternal immune activation (MIA) model of schizophrenia produces pre-pulse inhibition (PPI) deficits in both juvenile and adult rats but these effects are not associated with maternal weight loss. Behav Brain Res 213:323–327.
276. Wolff AR, Bilkey DK. 2015. Prenatal immune activation alters hippocampal place cell firing characteristics in adult animals. Brain Behav Immun 48:232–243.
277. Wolff AR, Cheyne KR, Bilkey DK. 2011. Behavioural deficits associated with maternal immune activation in the rat model of schizophrenia. Behav Brain Res 225:382–387.
278. Wu LJ, Stevens B, Duan S, MacVicar BA. 2013. Microglia in neuronal circuits. Neural Plast 2013:586426.
279. Xu G, Jing J, Bowers K, Liu B, Bao W. 2014. Maternal diabetes and the risk of autism spectrum disorders in the offspring: A systematic review and meta-analysis. J Autism Dev Disord 44:766–775.
280. Xuan ICY, Hampson DR. 2014. Gender-dependent effects of maternal immune activation on the behavior of mouse offspring. PLoS One 9.
281. Yang AC, Tsai SJ. 2017. New targets for schizophrenia treatment beyond the dopamine hypothesis. Int J Mol Sci 18.
282. Yang HM, Yang S, Huang SS, Tang BS, Guo JF. 2017. Microglial activation in the pathogenesis of Huntington's Disease. Front Aging Neurosci 9:193.
283. Yee N, Ribic A, de Roo CC, Fuchs E. 2011. Differential effects of maternal immune activation and juvenile stress on anxiety-like behaviour and physiology in adult rats: No evidence for the “double-hit hypothesis.” Behav Brain Res 224:180–188.
284. Yee N, Schwarting RKW, Fuchs E, Wöhr M. 2012. Increased affective ultrasonic communication during fear learning in adult male rats exposed to maternal immune activation. J Psychiatr Res 46:1199–1205.
285. Yin P, Liu J, Li Z, Wang YY, Qiao NN, Huang SY, Li BM, Sun RP. 2013. Prenatal immune challenge in rats increases susceptibility to seizure-induced brain injury in adulthood. Brain Res 1519:78–86.
286. Yin P, Zhang X-T, Li J, Yu L, Wang J-W, Lei G-F, Sun R-P, Li B-M. 2015. Maternal immune activation increases seizure susceptibility in juvenile rat offspring. Epilepsy Behav 47:93–97.
287. Yolken RH, Dickerson FB, Fuller Torrey E. 2009. Toxoplasma and schizophrenia. Parasite Immunol 31:706–715.
288. Young JW, Powell SB, Risbrough V, Marston HM, Geyer MA. 2009. Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol Ther 122:150–202.
289. Zager A, Mennecier G, Palermo-Neto J. 2012. Maternal immune activation in late gestation enhances locomotor response to acute but not chronic amphetamine treatment in male mice offspring: Role of the D1 receptor. Behav Brain Res 232:30–36.
290. Zager A, Pierre J, Mennecier G, Rodrigues SC, Aloia TP. 2015. Maternal immune activation in late gestation increases neuroinflammation and aggravates experimental autoimmune encephalomyelitis in the offspring. Brain Behav Immun 43:159–171.
291. Zager A, Pinheiro ML, Ferraz-De-Paula V, Ribeiro A, Palermo-Neto J. 2013. Increased cell-mediated immunity in male mice offspring exposed to maternal immune activation during late gestation. Int Immunopharmacol 17:633–637.
292. Zavitsanou K, Lim CK, Purves-Tyson T, Karl T, Kassiou M, Banister SD, Guillemin GJ, Weickert CS. 2014. Effect of maternal immune activation on the kynurenine pathway in preadolescent rat offspring and on MK801-induced hyperlocomotion in adulthood: Amelioration by COX-2 inhibition. Brain Behav Immun 41:173–181.
293. Zerbo O, Qian Y, Yoshida C, Grether JK, Van de Water J, Croen LA. 2015. Maternal Infection During Pregnancy and Autism Spectrum Disorders. J Autism Dev Disord 45:4015–4025.
294. Zhan Y, Paolicelli RC, Sforazzini F, Weinhard L, Bolasco G, Pagani F, Vyssotski AL, Bifone A, Gozzi A, Ragozzino D, Gross CT. 2014. Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. Nat Neurosci 17:400–406.
295. Zhang Y, Cazakoff BN, Thai CA, Howland JG. 2012. Prenatal exposure to a viral mimetic alters behavioural flexibility in male, but not female, rats. Neuropharmacology 62:1299–1307.
296. Zhang Z, van Praag H. 2015. Maternal immune activation differentially impacts mature and adult-born hippocampal neurons in male mice. Brain Behav Immun 45:60–70.
297. Zhou H. 2015. Region Specific Effects of Maternal Immune Activation on Offspring Neuroimmune Function. Open J Immunol 5:51–63.
298. Zhu F, Zheng Y, Liu Y, Zhang X, Zhao J. 2014. Minocycline alleviates behavioral deficits and inhibits microglial activation in the offspring of pregnant mice after administration of polyriboinosinic – polyribocytidilic acid. Psychiatry Res 219:680–686.
299. Zimmerman AW, Jyonouchi H, Comi AM, Connors SL, Milstien S, Varsou A, Heyes MP. 2005. Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neurol 33:195–201.
300. Zuckerman L, Rehavi M, Nachman R, Weiner I. 2003. Immune Activation During Pregnancy in Rats Leads to a PostPubertal Emergence of Disrupted Latent Inhibition, Dopaminergic Hyperfunction, and Altered Limbic Morphology in the Offspring: A Novel Neurodevelopmental Model of Schizophrenia. Neuropsychopharmacology 28:1778–1789.
301. Zuckerman L, Weiner I. 2005. Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J Psychiatr Res 39:311–323.